Guillermo de Anda-Jáuregui, Raúl A. Mejía-Pedroza, Jesús Espinal-Enríquez, Enrique Hernández-Lemus. Crosstalk events in the estrogen signaling pathway may affect tamoxifen efficacy in breast cancer molecular subtypes. Computers & Chemistry, 59:42-54, 2015. [doi]
@article{Anda-JaureguiME15,
title = {Crosstalk events in the estrogen signaling pathway may affect tamoxifen efficacy in breast cancer molecular subtypes},
author = {Guillermo de Anda-Jáuregui and Raúl A. Mejía-Pedroza and Jesús Espinal-Enríquez and Enrique Hernández-Lemus},
year = {2015},
doi = {10.1016/j.compbiolchem.2015.07.004},
url = {http://dx.doi.org/10.1016/j.compbiolchem.2015.07.004},
researchr = {https://researchr.org/publication/Anda-JaureguiME15},
cites = {0},
citedby = {0},
journal = {Computers & Chemistry},
volume = {59},
pages = {42-54},
}